Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial von Buzdar, A, Howell, A, Cuzick, J, Wale, C, Distler, W, Hoctin-Boes, G, Houghton, J, Locker, G Y, Nabholtz, J M

Volltext

Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: An EORTC G... von Vermorken, J. B., Zanetta, G., De Oliveira, C. F., van der Burg, M. E. L., Lacave, A. J., Teodorovic, I., Boes, G. Hoctin, Colombo, N.

Volltext

Phase I pharmacokinetic and pharmacodynamic study of the prenyl transferase inhibitor AZD3409 in patients with advanced cancer von Appels, N M G M, Bolijn, M J, Chan, K, Stephens, T C, Hoctin-Boes, G, Middleton, M, Beijnen, J H, de Bono, J S, Harris, A L, Schellens, J H M

Volltext

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer von Vergote, Ignace, Tropé, Claes G, Amant, Frédéric, Kristensen, Gunnar B, Ehlen, Tom, Johnson, Nick, Verheijen, René H.M, van der Burg, Maria E.L, Lacave, Angel J, Panici, Pierluigi Benedetti, Kenter, Gemma G, Casado, Antonio, Mendiola, Cesar, Coens, Corneel, Verleye, Leen, Stuart, Gavin C.E, Pecorelli, Sergio, Reed, Nick S

Volltext

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer von Howell, A, Cuzick, J, Baum, M, Buzdar, A, Dowsett, M, Forbes, J F, Hoctin-Boes, G, Houghton, J, Locker, G Y, Tobias, J S

Volltext

Bleomycin, Methotrexate, and CCNU in Locally Advanced or Recurrent, Inoperable, Squamous-Cell Carcinoma of the Vulva: An EORTC Gynaecological Cancer Cooperative Group Study von Wagenaar, H.C., Colombo, N., Vergote, I., Hoctin-Boes, G., Zanetta, G., Pecorelli, S., Lacave, A.J., van Hoesel, Q., Cervantes, A., Bolis, G., Namer, M., Lhommé, C., Guastalla, J.P., Nooij, M.A., Poveda, A., Scotto di Palumbo, V., Vermorken, J.B.

Volltext

Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy von Greimel, Elfriede, Kristensen, Gunnar B, van der Burg, Maria E.L, Coronado, Pluvio, Rustin, Gordon, del Rio, Angel Sanchez, Reed, Nicholas S, Nordal, Randi R, Coens, Corneel, Vergote, Ignace

Volltext

Identifying patients with a high risk of relapse in quiescent Crohn's disease von SAHMOUD, T, HOCTIN-BOES, G, MARY, J. Y, MODIGLIANI, R, BITOUN, A, COLOMBEL, J. F, SOULE, J. C, FLORENT, C, GENDRE, J. P, LEREBOURS, E, SYLVESTER, R

Volltext

The Effects of Neoadjuvant Anastrozole (Arimidex) on Tumor Volume in Postmenopausal Women with Breast Cancer: A Randomized, Double-Blind, Single-Center Study von DIXON, J. M, RENSHAW, L, BELLAMY, C, STUART, M, HOCTIN-BOES, G, MILLER, W. R

Volltext

Sample size estimation in phase III cancer clinical trials von Curran, D., Sylvester, R.J., Hoctin Boes, G.

Volltext

The ATAC (‘Arimidex’, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment von Duffy, S., Jackson, T.L., Lansdown, M., Philips, K., Wells, M., Pollard, S., Clack, G., Coibion, M., Bianco, A.R.

Volltext

Acute toxicity of alternating schedule of chemotherapy and irradiation in limited small-cell lung cancer in a pilot study (08877) of the EORTC Lung Cancer Cooperative Group von Gregor, A., Drings, P., Rinaldi, M., Schuster, L., Burghouts, J., Postmus, P. E., Dalesio, O., Kirkpatrick, A., Boes, G. Hoctin, Van Zandwijk, N.

Volltext

Cyclophosphamide or ifosfamide in patients with advanced and/or recurrent endometrial carcinoma: a randomized phase II study of the EORTC Gynecological Cancer Cooperative Group von Pawinski, A., Tumolo, S., Hoesel, G., Cervantes, A., van Oosterom, A.T., Hoctin Boes, G., Pecorelli, S.

Volltext

Letrozole for advanced breast cancer von Hoctin-Boes, G, Yates, R, Steinberg, M

Volltext

PP1. Resource implications of paclitaxel/cisplatinum versus cyclophosphamide/cisplatinum in the treatment of advanced ovarian cancer von Adriaenssen, I, Piccart, M, Roy, JA, Hoctin Boes, G

Volltext

EORTC 10941: A phase II study of liarozole in postmenopausal patients with 'chemotherapy-resistant' or 'potentially hormone sensitive' metastatic breast cancer von Hamilton, A, Roy, J A, Beex, L, Piccart, M, Mauriac, L, Coleman, R, Paridaens, R, Boes, G H, van Vreckem, A, Palmer, P, Klijn, J

Volltext

Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. Europe... von Wagenaar, H C, Colombo, N, Vergote, I, Hoctin-Boes, G, Zanetta, G, Pecorelli, S, Lacave, A J, van Hoesel, Q, Cervantes, A, Bolis, G, Namer, M, Lhommé, C, Guastalla, J P, Nooij, M A, Poveda, A, Scotto di Palumbo, V, Vermorken, J B

Volltext

Taxol (T) versus doxorubicin (D) as first-line chemotherapy (CT) in advanced breast cancer (ABC): An EORTC randomized study with crossover von Paridaens, R., Bruning, P., Klljn, J., Gamucci, T., Biganzoli, L., Van Vreckem, A., Hoctin Boes, G., Curran, D., Piccart, M.

Volltext

A new standard treatment for advanced premenopausal breast cancer: A meta-analysis of the Combined Hormonal Agent Trialists Group (CHAT) von Klijn, J.G.M., Blarney, R.W., Boccardo, F., Tominaga, T., Jonat, W., Kaufmann, M., Beex, L., Mauriac, L., Hoctin-Boes, G., Duchateau, L., Sylvester, R.

Volltext

EORTC-IDBBC (Investigational Drug Branch For Breast Cancer): 5 Years of European collaboration in new drug development for breast cancer von Awada, A, Van Vreckem, A, Paridaens, R, Bruning, P.F, Klijn, J, Tomiak, E, Vinholes, J, Roy, J.A, Kusenda, Z, Hoctin Boes, G, Van Glabbeke, M, Piccart, M.J

Volltext